Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Extract Labs is a commercially active, veteran-owned company specializing in cannabinoid-based wellness products, including CBD, CBG, CBN, THC, and other minor cannabinoids, with a focus on quality, accessibility, and transparency. They emphasize in-house CO2 extraction, third-party lab testing, and ethical manufacturing. Products are distributed both B2B and B2C and are FDA-registered and GMP-certified. The company is known for its veteran and community discount programs and a wide product portfolio. Extract Labs has been acquired by CV Sciences, but remains a stand-alone brand with its own manufacturing and distribution. [1][2][4]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Extract Labs.